KhabarCheckखबर चेक
← Top Stories

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

Partially corroborated56

The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.

First seen · latest update · World · business

Developing: this story surfaced recently from a single outlet. It appears early by design — expect the reporting-confidence score to move as more outlets report (or don’t).

  • Indian mainstream 0
  • Indian independent 0
  • International 1
  • Official 0
Share

Coverage (1)

See a mistake? Wrong summary · Wrongly grouped · Missing source · Wrong category/region · Dispute outlet rating — each opens a pre-filled report on GitHub.